EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Sex-based differences in streptozotocin-induced type 2 diabetes rat models

Ugljesa Malicevic, Jacob Smith, Devendra K. Agrawal, Vikrant Rai

Journal of Clinical and Translational Research · 2025-10-28 · 11 (6) · 20

DOI: 10.36922/jctr025170020 ↗
AbstractBibliografische Angaben

Abstract

Background: Diabetic foot ulcers (DFUs) are a severe complication of diabetes mellitus, leading to chronic infections, amputations, and increased mortality despite existing treatments. More effective therapeutics are urgently needed, and animal models provide a critical platform for investigating the molecular mechanisms underlying DFUs. Streptozotocin (STZ)—administered at a low dose to induce type 2 diabetes (T2D) and at a high dose to induce type 1 diabetes—is commonly used in mice and rats in DFU research. Aim: The objective of this study is to highlight the importance of including male and female rats in DFU research. Methods: Both male and female Sprague–Dawley rats, 6–8 weeks old, were fed a high-fat diet for 9 weeks. STZ (25 mg/kg intraperitoneally) was administered weekly from the 6th week to induce T2D. Results: Female rats required a higher dose of STZ compared to male rats. The induction of T2D correlated positively with weight gain, which was greater in males than in females. Conclusion: The findings suggest that in addition to gender and weight, other factors may influence the induction of T2D in rats. Most studies in the literature do not use both sexes in DFU research. The distinct responses to STZ and weight gain observed emphasize the need to include both sexes and employ a more detailed approach in preclinical studies to enhance the understanding of DFU wound healing and translate the findings into potential treatments. Relevance for patients: The multifactorial effect on diabetes development, which differs in males and females, suggests the need to consider etiological, physiological, and demographic factors, such as body weight, gender, age, and body mass index, in the prevention and treatment of diabetes. This will also help in planning the individualized treatment for DFUs.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →